Intrathecal hyperbaric bupivacaine versus hyperbaric ropivacaine in spinal anaesthesia in caesarean sections: a randomised control trial in a teaching hospital in northeast India.
- Conditions
- Health Condition 1: O298- Other complications of anesthesiaduring pregnancy
- Registration Number
- CTRI/2024/05/067399
- Lead Sponsor
- eon
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
i.All patients who will be registered for elective caesarean delivery and belonging to ASA (American Society of Anesthesiologists) grade I & II only.
ii.Patients between 145to 165 cms of height.
iii.Patients who will give valid informed written consent.
iv.Pregnancy over 37 weeks and less than 42 weeks.
v.Patient with weight of 45-95kgs.
vi.Patients with age between 18years and 40 years.
i.Patient with abnormalities and problems in the embryo.
ii.Patient with indication of an emergency caesarean section.
iii.Patients having history of hypersensitivity to anesthetic agents.
iv.Infection at the subarachnoid block injection site.
v.Pre-term and post term delivery.
vi.ASA class higher than II.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method